Unknown

Dataset Information

0

Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.


ABSTRACT: The amyloid-forming proteins tau, ?B crystallin, and amyloid P protein are all found in lesions of multiple sclerosis (MS). Our previous work established that amyloidogenic peptides from the small heat shock protein ?B crystallin (HspB5) and from amyloid ? fibrils, characteristic of Alzheimer's disease, were therapeutic in experimental autoimmune encephalomyelitis (EAE), reflecting aspects of the pathology of MS. To understand the molecular basis for the therapeutic effect, we showed a set of amyloidogenic peptides composed of six amino acids, including those from tau, amyloid ? A4, major prion protein (PrP), HspB5, amylin, serum amyloid P, and insulin B chain, to be anti-inflammatory and capable of reducing serological levels of interleukin-6 and attenuating paralysis in EAE. The chaperone function of the fibrils correlates with the therapeutic outcome. Fibrils composed of tau 623-628 precipitated 49 plasma proteins, including apolipoprotein B-100, clusterin, transthyretin, and complement C3, supporting the hypothesis that the fibrils are active biological agents. Amyloid fibrils thus may provide benefit in MS and other neuroinflammatory disorders.

SUBMITTER: Kurnellas MP 

PROVIDER: S-EPMC3684024 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.

Kurnellas Michael P MP   Adams Chris M CM   Sobel Raymond A RA   Steinman Lawrence L   Rothbard Jonathan B JB  

Science translational medicine 20130401 179


The amyloid-forming proteins tau, αB crystallin, and amyloid P protein are all found in lesions of multiple sclerosis (MS). Our previous work established that amyloidogenic peptides from the small heat shock protein αB crystallin (HspB5) and from amyloid β fibrils, characteristic of Alzheimer's disease, were therapeutic in experimental autoimmune encephalomyelitis (EAE), reflecting aspects of the pathology of MS. To understand the molecular basis for the therapeutic effect, we showed a set of am  ...[more]

Similar Datasets

| S-EPMC9844993 | biostudies-literature
| S-EPMC2715474 | biostudies-other
| S-EPMC7316157 | biostudies-literature
| S-EPMC2660777 | biostudies-literature
| S-EPMC3079736 | biostudies-literature
| S-EPMC3757175 | biostudies-literature
| S-EPMC3446680 | biostudies-literature
| S-EPMC3942478 | biostudies-literature
| S-EPMC5485726 | biostudies-literature
| S-EPMC2526019 | biostudies-literature